Skip to main content
Lipocine Inc. logo

Lipocine Inc. — Investor Relations & Filings

Ticker · LPCN ISIN · US53630X1046 LEI · 549300RXPEQXOJXVBI10 US Manufacturing
Open in API
Filings indexed 786 across all filing types
Latest filing 2019-04-11 Regulatory Filings
Country US United States of America
Listing US LPCN

About Lipocine Inc.

https://www.lipocine.com/

Lipocine Inc. is a clinical-stage biopharmaceutical company that develops treatments for metabolic, endocrine, and central nervous system disorders. The company leverages its proprietary Lip'ral drug delivery technology to enhance the oral absorption of water-insoluble drugs, aiming to improve patient compliance and therapeutic outcomes. Its portfolio includes TLANDO®, an FDA-approved oral testosterone replacement therapy. Lipocine's development pipeline features candidates for conditions such as non-alcoholic steatohepatitis (NASH), postpartum depression, obesity, and prevention of preterm birth. The company's strategy often involves using the 505(b)(2) regulatory pathway to develop improved formulations of established drugs.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text mentions a presentation made at The International Liver Congress 2019 and that the presentation is filed as an exhibit. There is no detailed financial data or comprehensive report content included in the text. The document length is 2881 characters, which is relatively short and consistent with an announcement rather than a full report. The content fits the description of a Regulatory Filing (RNS) as it is a general regulatory announcement reporting an event (presentation) without substantive financial statements or detailed analysis. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-04-11 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions an "Other Events" section where the company announces seeking an injunction against a competitor's product. There are no financial statements or detailed financial data included, nor is this an annual or quarterly report. The document is short (3008 characters) and primarily serves as a regulatory announcement of a legal action event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2019-04-03 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate updates. The text specifically mentions that the company has updated its corporate presentation and LPCN 1144 presentation for investors and analysts, and these presentations are filed as exhibits. There is no detailed financial data, earnings information, or comprehensive report content. The document is short (2965 characters) and primarily serves as an announcement of updated investor presentations. According to the classification rules, such updates to presentations filed as exhibits in an 8-K correspond to an Investor Presentation (IP) filing type rather than a full report or other categories. Therefore, the correct classification is Investor Presentation (IP).
2019-03-28 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text indicates it is reporting 'Other Events' specifically a press release about ABPM labeling study results. The document is short (2880 characters) and primarily references a press release filed as an exhibit. There are no financial statements or detailed financial data included. This fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Earnings Release or Annual Report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-03-27 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes a press release about acceptance of an abstract for a late-breaker presentation at a medical congress, and it references exhibits including a press release and an abstract. There are no financial statements or detailed financial data included. The document is relatively short (3677 characters) and primarily serves as an announcement of an event and related materials. Therefore, it is not an Annual Report, Earnings Release, or Interim Report. It is also not a Management or Board change announcement. The document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2019-03-26 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate updates. The text specifically mentions an update to the company's corporate presentation used for investor meetings, and that the presentation is filed as an exhibit. The document is short (2759 characters) and does not contain detailed financial statements or substantive financial data. It is primarily an announcement of an updated investor presentation rather than the presentation itself or a detailed financial report. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories.
2019-03-18 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.